Puretech gains after FDA meeting post-Phase II trial PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) shares rose 4.9% to 128p on Wednesday after the company said it had completed a…
PureTech Health issues shares to executives following RSU vesting By Investing.com PureTech Health issues shares to executives following RSU vesting…
PureTech Health announces RSU vesting and share transactions by PDMR By Investing.com PureTech Health announces RSU vesting and share transactions by PDMR…